X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9562) 9562
Publication (1055) 1055
Book Review (153) 153
Book Chapter (52) 52
Conference Proceeding (22) 22
Newspaper Article (6) 6
Magazine Article (5) 5
Data Set (3) 3
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rituximab (8133) 8133
humans (7727) 7727
index medicus (5925) 5925
female (4329) 4329
male (4303) 4303
middle aged (3702) 3702
adult (3102) 3102
aged (2934) 2934
hematology (2675) 2675
treatment outcome (2654) 2654
oncology (2467) 2467
antibodies, monoclonal, murine-derived (1981) 1981
therapy (1937) 1937
antibodies, monoclonal - therapeutic use (1657) 1657
antineoplastic combined chemotherapy protocols - therapeutic use (1544) 1544
chemotherapy (1502) 1502
lymphomas (1343) 1343
care and treatment (1322) 1322
transplantation (1199) 1199
antibodies, monoclonal, murine-derived - therapeutic use (1187) 1187
aged, 80 and over (1185) 1185
non-hodgkins-lymphoma (1183) 1183
cancer (1176) 1176
antibodies, monoclonal - adverse effects (1123) 1123
cyclophosphamide (1111) 1111
retrospective studies (1058) 1058
lymphoma (1039) 1039
antineoplastic agents - therapeutic use (993) 993
antineoplastic combined chemotherapy protocols - adverse effects (970) 970
antibodies, monoclonal, murine-derived - adverse effects (957) 957
medicine & public health (947) 947
rheumatology (935) 935
adolescent (915) 915
immunology (905) 905
young adult (904) 904
immunosuppressive agents - therapeutic use (883) 883
prognosis (877) 877
antibodies, monoclonal, murine-derived - administration & dosage (853) 853
drug therapy (842) 842
immunologic factors - therapeutic use (834) 834
antibodies, monoclonal - administration & dosage (828) 828
risk factors (818) 818
recurrence (790) 790
antineoplastic agents - adverse effects (784) 784
patients (754) 754
rituximab - therapeutic use (742) 742
efficacy (730) 730
cyclophosphamide - administration & dosage (726) 726
b-cell lymphoma (722) 722
immunotherapy (715) 715
disease-free survival (695) 695
survival (691) 691
trial (686) 686
health aspects (683) 683
disease (678) 678
analysis (676) 676
follow-up studies (657) 657
remission induction (656) 656
research (648) 648
monoclonal antibodies (627) 627
lymphoma, large b-cell, diffuse - drug therapy (626) 626
leukemia, lymphocytic, chronic, b-cell - drug therapy (600) 600
antineoplastic agents (597) 597
antineoplastic combined chemotherapy protocols - administration & dosage (593) 593
child (590) 590
anti-cd20 monoclonal-antibody (588) 588
pharmacology & pharmacy (583) 583
safety (581) 581
antimitotic agents (571) 571
chronic lymphocytic-leukemia (567) 567
rheumatoid arthritis (561) 561
abridged index medicus (548) 548
follicular lymphoma (534) 534
time factors (529) 529
clinical trials (528) 528
drug administration schedule (517) 517
drug therapy, combination (511) 511
rituximab - adverse effects (505) 505
hemic and lymphatic diseases (501) 501
diagnosis (500) 500
vincristine - administration & dosage (500) 500
rituximab - administration & dosage (487) 487
double-blind (480) 480
immunosuppressive agents - adverse effects (480) 480
doxorubicin - administration & dosage (476) 476
lymphoma, non-hodgkin - drug therapy (468) 468
arthritis, rheumatoid - drug therapy (466) 466
medicine, general & internal (461) 461
prednisone - administration & dosage (458) 458
rheumatoid-arthritis (455) 455
antirheumatic agents - therapeutic use (449) 449
cyclophosphamide - therapeutic use (449) 449
fludarabine (447) 447
cyclophosphamide - adverse effects (443) 443
animals (437) 437
remission (434) 434
antineoplastic agents - administration & dosage (432) 432
immunologic factors - adverse effects (431) 431
elderly-patients (430) 430
article (425) 425
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9243) 9243
German (71) 71
Spanish (67) 67
French (66) 66
Japanese (54) 54
Chinese (29) 29
Russian (16) 16
Italian (10) 10
Korean (10) 10
Czech (9) 9
Polish (7) 7
Croatian (6) 6
Danish (6) 6
Hungarian (4) 4
Dutch (3) 3
Portuguese (3) 3
Finnish (2) 2
Hebrew (2) 2
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2011, Volume 2011, Issue 2, p. CD008794
Journal Article
Rheumatology (United Kingdom), ISSN 1462-0324, 03/2017, Volume 56, Issue 3, pp. 417 - 425
Journal Article
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, ISSN 0392-856X, 09/2019, Volume 37, Issue 5, pp. 858 - 861
Objective. To study the efficacy in terms of muscle strength, and corticosteroid tapering as well as the prevalence of adverse effects in patients with the... 
INTERSTITIAL LUNG-DISEASE | THERAPY | POLYMYOSITIS | RITUXIMAB | antisynthetase syndrome | myositis | methotrexate | azathioprine | EXPERIENCE | COHORT | RHEUMATOLOGY | MYCOPHENOLATE-MOFETIL
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9873, pp. 1203 - 1210
Summary Background Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of... 
Internal Medicine | SURVIVAL | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | II MULTICENTER | B-CELL | ADVANCED FOLLICULAR LYMPHOMA | CYCLOPHOSPHAMIDE | VINCRISTINE | NON-HODGKINS-LYMPHOMA | COMBINATION | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Nitrogen Mustard Compounds - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Vincristine - administration & dosage | Adult | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Treatment Outcome | Nitrogen Mustard Compounds - adverse effects | Disease-Free Survival | Bendamustine Hydrochloride | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Aged | Infusions, Intravenous | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Usage | Chemotherapy | Bendamustine | Patient outcomes | Lymphomas | Research | Drug therapy | Comparative analysis | Cancer | Antimitotic agents | Care and treatment | Antineoplastic agents | Analysis | Bone marrow | Hematology
Journal Article